Tympanogen

Richmond, United States

Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.

$1.2M raised

Mar 2025

Venture - Series Unknown

Top Investors

MassChallengeVirginia Venture PartnersShockVenturesNO/LA Angel NetworkVirginia Catalyst

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Tympanogen raised?

Tympanogen has raised $1.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.

Who are Tympanogen's investors?

Tympanogen's investors include MassChallenge, Virginia Venture Partners, ShockVentures, NO/LA Angel Network, Virginia Catalyst.

Where is Tympanogen headquartered?

Tympanogen is headquartered in Richmond, United States.

What does Tympanogen do?

Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.

What stage is Tympanogen at?

Tympanogen is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 13, 2025.

MLA

"Tympanogen — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/tympanogen. Accessed June 4, 2026.

APA

VCBacked. (2025). Tympanogen — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/tympanogen

Wikipedia (cite web)

{{cite web |title=Tympanogen — Funding & Investors |url=https://www.vcbacked.co/company/tympanogen |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 13, 2025.